NCT00009789 Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction Status COMPLETED Phase PHASE1
NCT00008385 Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00008372 Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00008333 Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00008255 INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer Status COMPLETED Phase PHASE2
NCT00006981 Immunotoxin Therapy in Treating Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00006877 Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00006487 S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00006484 Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00006470 Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery Status COMPLETED Phase PHASE2
NCT00006469 Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00006458 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer Status UNKNOWN Phase PHASE1
NCT00006457 Oltipraz in the Prevention of Lung Cancer in People Who Smoke Status COMPLETED Phase PHASE1
NCT00006378 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00006374 Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT00006370 Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00006368 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Status COMPLETED Phase PHASE1
NCT00006352 Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00006349 Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer Status COMPLETED Phase PHASE3